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Background: The aim of this meta-analysis was to analyse the outcomes of major pancreatic surgery
among the elderly (75 and 80 years of age).
Methods: A systematic literature search was conducted using Embase, MEDLINE, Cochrane and
PubMed databases on all studies published between January 1990 and April 2012 reporting peri-
operative outcomes after a pancreaticoduodenectomy (PD) among the elderly. Primary end-points mea-
sured were peri-operative mortality and the incidence of post-operative complications. Secondary
outcomes considered included the incidence of post-operative pancreatic fistula formation (POPF),
delayed gastric emptying (DGE), wound infection, pneumonia, post-operative bleeding and length of
hospital stay.
Results: Eleven trials were included comprising 5186 patients; 7 studies comparing endpoints in
patients aged 75 years vs. younger populations and 4 studies comparing endpoints in patients aged
80 years vs. younger populations. In both groups, there was a statistically significant increase in the
incidence of mortality and post-operative pneumonia in the elderly population. The incidence of post-
operative complications was also found to be statistically significant among patients80 years of age vs.
their younger cohorts.
Conclusions: There is an increased incidence of post-operative mortality and pneumonia after a PD
among all elderly patients 75 years of age, as well as an increased incidence of post-operative
complications among patients 80 years of age. Additional randomized control trials studying post-PD
operative outcomes in elderly vs. younger patients with standardization of comorbidities is therefore
necessary to confirm the conclusions presented here.
Received 25 April 2012; accepted 16 May 2012
Correspondence
Sukharamwala Prashant, Northside Medical Center, Department of General Surgery, 500 Gypsy lane,
Youngstown, OH 44501, USA. Tel: +1 646 671 2057. Fax: +1 330 884 3815. E-mail:
Prashantsukharamwala@yahoo.com
Introduction
The US Census Bureau projects that the population of Americans
over 65 years will double within the next three decades.1 A 2008
report by this department’s Population Projection Branch esti-
mated that the average life expectancy will increase from 75.9
years in 1995 to 79.1 years in 2025.2 Over this time period,
healthcare providers can expect to see an increase in the incidence
of cancer and cancer-related mortality, particularly among elderly
populations. Just as morbidity and mortality increase with
advancing age, the feasibility and effectiveness of available treat-
ment methods diminish. As a result, the risks of treatment-related
morbidity and associated burdens of protracted supportive care
are similarly expected to increase.
Pancreaticoduodenectomy (PD) remains the sole potentially
curative intervention for several types of peri-ampullary and
pancreatic carcinomas as well as several benign lesions of the
pancreas such as chronic pancreatitis and mass lesions within the
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pancreatic head. Pancreatic cancer alone represents the tenth most
common form of cancer in the United States and is currently the
fourth leading cause of cancer-related death among all Ameri-
cans.3 According to the National Cancer Institute, it is estimated
that as many as 43 920 citizens will be diagnosed with pancreatic
cancer in 2012 and an additional 37 390 will die of the disease this
year alone.4Between 2004 and 2008, the median age at the time of
diagnosis for pancreatic cancer was 72 years. Further analysis
shows that 25.4% of patients were between the ages 65 and 74
years, 28.6% were between the ages 75 and 84 years and 13.3%
were 85+ years of age at the time of diagnosis.5 As American
demographics continue to shift towards the aged, the incidence of
pancreatic and peri-ampullary cancer is expected to increase sig-
nificantly among the elderly population. Within the last two
decades, a number of authors have published data on peri-
operative outcomes of pancreatic surgery among the elderly with
varying reports of overall efficacy.6–16
The aim of this study was to analyse the outcomes after major
pancreatic surgery among the elderly (75 years of age and
80 years of age) vs. that of the younger (<75 years of age and
<80 years of age) population in order to determine whether
major pancreatic surgery is indeed efficacious among the elderly
population.
Methods
A systematic literature search was conducted using Embase,
MEDLINE, Cochrane and PubMed databases on all studies pub-
lished between January 1990 and April 2012 reporting peri-
operative outcomes after a PD among the elderly. The following
medical subject headings (MeSH) were used: ‘Whipple procedure’,
‘pancreaticoduodenectomy in the elderly’, ‘surgical resection of
pancreatic cancer’, ‘risk factor for major pancreatic surgery’ and
‘major abdominal surgery in octogenarians’. The ‘related articles’
function was used to broaden the search and all abstracts, studies
and citation results were reviewed. In addition, bibliographies of
all included studies were screened for any potentially relevant
studies.
Data extraction
Three reviewers (S.P., T.J. and D.P.) independently extracted the
following data from each study: first author, year of publication,
study population characteristics, study design, number of subjects
operated on with each technique, comorbidities and peri-operative
outcome. Studies were included that reported peri-operative out-
comes in both patients 75 years as well as 80 years of age. A
separate meta-analysis was performed for the two population age
groups: 75 years of age and 80 years of age. As none of the
included studies were randomized control trials, Jadad’s scoring
system was not used; however, quality guidelines were adherent to
QUOROM (Quality of Reporting of Meta-analyses) statements in
order to increase transparency of conclusions made by the
authors.17 Methodological qualities were independently assessed
and any discrepancies were resolved with detailed discussion. A
QUOROM flow chart was also obtained (Fig. 1).
Inclusion criteria
We included studies which compared peri-operative outcomes
after a PD on elderly (75 years of age and80 years of age) with
younger age patient (<75 and <80 years of age) populations,
reported on at least one of the outcome measures, and matched
their population groups.
Exclusion criteria
Studies were excluded from this analysis if they reported the
outcome of interest for patients 70 years of age, if the adequate
data were not available from the published results, or if the study
groups were not matched. The 2009 study by Balarian et al.8 was
omitted in light of new data published by the same author in
2010.9
Outcomes of interest
Post-operative outcomes were compared among two principal
populations: patients aged 75–79 years and 80 years, and com-
pared with their younger counterparts. Primary end-points
measured were peri-operative mortality and the incidence of
post-operative complications. Secondary outcomes considered
were the incidence of post-operative pancreatic fistula formation
(POPF), delayed gastric emptying (DGE), wound infection,
pneumonia, post-operative bleeding and length of hospital stay.
Peri-operative mortality was defined as death occurring during
hospitalization or within 30 post-operative days. A post-operative
pancreatic fistula was defined using The International Study
Group on Pancreatic Fistula criteria.18
Statistical analysis
Data on the outcome of interest were entered into a digital data-
base spreadsheet for analysis. Data analysis was performed utiliz-
ing the freeware program Review Manager [Review Manager
(RevMan) Version 5.1; The Nordic Cochrane Centre, Copen-
hagen, Denmark] For dichotomous data, the Mantel–Hansel
method was employed with a fixed-effect model with a 95% con-
fidence interval (CI). For continuous data reported as mean and
standard deviation, an inverse variance method was used with a
fixed effect model and a 95% CI. Results were considered to be
statistically significant with a P-value <0.05 provided the 95% CI
did not include the value 1. The data for various outcomes were
entered and a Forest plot was generated. A funnel plot of the
primary outcomes was obtained in an effort to identify any pub-
lication bias.19 The funnel plot was roughly symmetrical with
minimal publication bias (Figs 2,3).
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Results
The preliminary literature search returned 101 studies matching
the initial search criteria. After screening, seven studies comparing
75 years of age populations6–12 and four studies comparing
octogenarian populations13–16 were selected for analysis. In total,
461 patients <75 years of age were compared with 161 patients75
years of age.Similarly,333 patients80 years of age were compared
with 4226 patients <80 years of age. The demographics of the study
populations, morbidity and mortality data are listed in Table 1.
Potentially relevant studies identified and
screened for retrieval 
n = 101  
Studies excluded n = 75 
Reason: non relevant studies. 
Potentially appropriate studies to be 
included in the meta-analysis  
n = 26  
Studies included in meta-analysis
n = 12  
Studies with usable information, by 
outcome,  
n = 11 
Studies withdrawn, by outcome, n = 1 
Reason: author released new data a year 
later 
Studies excluded from meta-analysis n = 14 
Reasons: 
Studies reported data on elderly ≥ 70  
Studies reported data without comparision 
with younger population 
Figure 1 Study flow diagram in accordance with the Quality of Reporting of Meta-analyses (QUOROM) statement
Figure 2 Funnel plot (mortality in elderly 75 years of age)
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Six6,7,9–12 and four13–16 trials reported on the incidence of post-
operative mortality among elderly patients 75 years of age and
80 years of age vs. younger populations, respectively. There was
a statistically significant difference among both groups favouring
younger patients [75 years of age: odds ratio (OR) 5.67, 95% CI
= 2.14 to 15.02, P < 0.0005; 80 years of age: OR 2.14, 95% CI =
1.15 to 3.98, P = <0.02] (Figs 4,5). However, there was a statisti-
cally significant increased prevalence of pre-operative coronary
artery disease in the elderly 75 years of age (OR 2.45, 95% CI =
1.46 to 4.10, P < 0.0007).
There was a statistically significant increase in the incidence of
post-operative pneumonia among the elderly group (75 years of
age, OR 5.03, 95% CI = 2.45 to 10.34, P < 0.0001;80 years of age,
OR 2.82, 95% CI = 1.62 to 4.92, P < 0.0003) (Figs 6,7). There was
also a statistically significant increase in post-operative complica-
tions among patients80 years of age (OR 1.62, 95% CI = 1.30 to
2.03, P < 0.0001) (Fig. 8), although there was no significant dif-
ference between patients 75 years of age and the younger age
group (OR 1.12, 95% CI = 0.77 to 1.64, P = 0.55) (Fig. 9).
There was no statistical difference in the incidence of pancreatic
fistula formation (75 years of age, OR 1.257, 95% CI = 0.75 to
2.08, P = 0.38; 80 years of age, OR 1.07, 95% CI = 0.73 to 1.58,
P = 0.74) or delayed gastric emptying (75 years of age, OR 0.99,
95% CI = 0.55 to 1.81, P = 0.98;80 years of age, OR 1.36, 95% CI
= 0.98 to 1.89, P = 0.07) among either groups.
Likewise there was no statistical difference in the incidence of
wound infection (75 years of age: OR 1.06, 95% CI = 0.63 to 1.77,
P= 0.83;80 years of age, OR 1.09, 95% CI= 0.73 to 1.61,P= 0.68).
There was also no statistical difference in post-operative bleeding
(OR 1.63, 95 % CI = -0.72 to 3.68, P = 0.24) or length of hospital
stay [standard mean difference (SMD) 0.15, 95 % CI = -0.06 to
0.35, P = 0.16] among patients 75 years of age vs. the younger
cohorts, although there was insufficient data to make similar
evaluations among the80 years of age cohorts (Tables 2,3).
Discussion
While the overall incidence of cancer and cancer-related deaths in
the US has been declining since 1998,20 the incidence of pancreatic
cancer and related deaths has been rising.4 Since 2004, the inci-
dence of pancreatic cancer and pancreatic cancer-related deaths
among the US population has increased by 1.5% and 0.5% per
year, respectively.22 Moreover, the 1- and 5-year survival rates
between the years 2001 and 2007 have been an abysmal 26% and
6%, respectively,21 making pancreatic cancer among the most sin-
ister carcinomas today.
To date, PD remains the sole potentially curative intervention
in many of these cases. Previous studies have demonstrated
improved outcomes after PD when performed at high volume
centres.22 Various factors that have been identified to affect the
peri-operative outcome after PD are site of origin, pre-operative
jaundice, microscopic positive margin, nodal metastasis, lym-
phovascular invasion, neural invasion and poorly differentiated
tumours.5,23
In spite of the improved outcomes observed at high volume
centres, the incidence of post-operative complications remains
high, as much as 21% to 73.6% among patients <75 years of age
and 31.5% to 57% among patients 75 years of age (Table 1). In
2006, Makary et al. conducted the largest retrospective analysis of
post-PD outcomes according to age yet produced. They analysed
the records of 2698 patients who underwent PD at The Johns
Hopkins Hospital between April 1970 and March 2005, of which
Figure 3 Funnel plot (mortality in elderly 80 years of age)
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Table 1 Demographics and outcomes of the study population6–16
Author Age N Age Gender
(male/
female)
Pancreatic
cancer
Ampullary
cancer
Duodenal
cancer
Bile duct
cancer
Mortality
n (%)
Morbidity
n (%)
Bathe et al. (2000)6 75 16 – – 11 2 1 1 4 (25) 7 (43.5)
<75 54 – – 31 17 1 1 2 (3.7) 28 (51.5)
Scurtu et al. (2008)7 75 32 – 14/18 20 3 – 3 6 (6.2) 10 (31.5)
<75 38 – 18/20 27 4 – 3 0 8 (21)
Ballarin et al. (2010)9 75 25 76.9  2.5 12/13 15 3 1 1 1 (4) 15 (60)
<75 80 56.9  11.4 33/47 37 6 1 2 1 (1.3) 39 (48.7)
Ito et al. (2011)10 75 31 79.09  3.49 16/15 8 5 0 15 1 (3.2) 39 (48.7)
<75 67 61.69  6.37 45/22 31 3 3 22 0 31 (46.2)
Barbas et al. (2012)11 75 32 – 13/19 – – – – 3 (9) 22 (69)
<75 171 – 93/78 – – – – 4 (2.3) 126 (73.6)
Yamada et al. (2012)12 75 25 78.6  3.6 13/15 6 – 1 12 0 16 (57.1)
<75 56 64.7  6.7 36/20 20 – 3 15 0 33 (58.9)
Total 75 161
<75 466
Sohn et al. (1998)13 80 46 82.9  2.7 19/27 25 9 2 5 2 (4.3) 26 (57)
<80 681 60.9  12.4 377/304 282 74 29 69 10 (1.6) 270 (41)
Makary et al. (2006)14 80 207 82 (80–89)a 95/112 96 31 11 24 8 (3.8) 109 (52.6)
<80 2491 64 (15–79)a 1351/1140 1014 257 102 218 42 (1.7) 984 (41.6)
Khan et al. (2010)15 80 53 – – – – – – 1 (2) 27 (51)
<80 564 – – – – – – 6 (1) 209 (37)
Hatzaras et al. (2011)16 80 27 83.4 (80–91)b 14/13 24 – – – 1 (3.7) 14 (52)
<80 490 61.8 (20–79)b 273/217 399 – – – 18 (3.7) 289 (59)
Total 80 333
<80 4226
aAge in median age, years (range).
bAge in mean age, years (range) – Data not available.
Figure 4 Forest plot of comparison of post-operative mortality in elderly 75 years of age
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92.3% (n = 2491) were <80 years old, 7.3% (n = 197) were 80 to 89
years old and 0.4% (n = 1) were 90 years old.14 They reported
morbidity rates of 41.6% (n = 984), 52.8% (n = 104) and 50% (n
= 5) among patients <80, 80 to 89 and90 years old, respectively.
Likewise, their observed mortality rates were 1.7% (n = 42), 4.1%
(n = 8) and 0% (n = 0) 3.8% among patients <80, 80 to 89 and90
years old, respectively (the later presumptively owing to a small
sample size). Furthermore, they reported similarly increasing
trends in the incidence of post-operative cardiac events and pneu-
monia. These findings were consistent with the present study.
Casedei and colleagues found that among their elderly patient
population undergoing peri-ampullary or pancreatic tumour
resection, co-morbidities such as chronic obstructive pulmonary
disease and coronary artery disease (CAD) were associated with
significantly higher mortality rates.24 They further noted that
elderly patients stratified according to the American Society of
Anesthesiologists (ASA) physical status classification system as
class 3 or higher were associated with significantly higher morbid-
ity. In another study, Sohn et al. demonstrated a significantly
higher incidence of post-operative complications in octagenarians
(57% vs. 41%, P = 0.05), leading to an increased length of stay
compared with their younger counterparts.13 Similar results were
later reported by Khan et al. who demonstrated increased post-
operative complications (P = <0.0004) among patients >80 years
Figure 5 Forest plot of comparison of post-operative mortality in elderly 80 years of age
Figure 6 Forest plot of comparison of post-operative pneumonia in elderly 75 years of age
Figure 7 Forest plot of comparison of post-operative pneumonia in elderly 80 years of age
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of age.15 The authors noted that in comparison to their younger
patient populations, the octogenarian group had significantly
more patients with poor risk factors with respect to ASA status (P
= <0.001), making patients 80 years of age much more suscep-
tible to post-operative complications. However, no studies to date
have identified any statistically significant difference in the inci-
dence of post-operative abscess, pancreatic fistula formation,
post-operative bleeding or wound infection, through their com-
parison of patients 75 years and 80 years of age to younger
populations.
The present study has several limitations. The increased preva-
lence of pre-operative comorbidities generally observed among
elderly populations potentially introduces significant selection
bias when comparing post-operative outcomes with younger
Figure 8 Forest plot of comparison of post-operative complications in elderly 80 years of age
Figure 9 Forest plot of comparison of post-operative complications in elderly 75 years of age
Table 2 Comparison of peri-operative outcomes in elderly 75 years of age vs. younger <75 years of age
Outcome Number
of studies
Participants Odds ratio
(M-H, Fixed, 95% CI)
Statistical
difference
Length of stay 5 539 0.15 [-0.06, 0.35]a NS (P = 0.16)
Post-operative complications 6 630 1.12 [0.77, 1.64] NS (P = 0.55)
Mortality 6 630 5.67 [2.14, 15.02] S (P = 0.0005)
Pancreatic fistula 6 630 1.25 [0.75, 2.08] NS (P = 0.38)
Wound infection 6 630 1.06 [0.63, 1.77] NS (P = 0.83)
Delayed Gastric Emptying 6 630 0.99 [0.55, 1.81] NS (P = 0.98)
Pneumonia 6 630 5.03 [2.45, 10.34] S (P < 0.0001)
Bleeding 6 630 1.63 [0.72, 3.68] NS (P = 0.24)
aStandard mean difference (IV, Fixed, 95% CI).
S, significant; NS, non-significant.
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cohorts without similar physical histories. Also, the data utilized
included several studies that were retrospective in design, leading
to the potential introduction of additional selection and informa-
tion bias. In addition, the outcome of any major abdominal
surgery heavily depends upon the expertise and clinical experi-
ence of the operating surgeon, a highly qualitative factor which
cannot be easily standardized. Several additional factors have also
been shown to affect patient outcomes: pre-operative nutritional
status, cachexia, time since diagnosis, metastasis affecting progno-
sis, neo-adjuvant or adjuvant therapy,25 and these factors were not
taken into account in several studies. Individual surgeon’s expe-
rience and institutional volume also affect the peri-operative out-
come,22 which could not be assessed from their published data.
Only a minority of elderly patients who presents with the disease
may choose to undergo the procedure, potentially leading to a
massive selection bias. The pre-operative functional status may
also contribute to the selection of these patients. There have been
several developmental improvements in operative outcome, the
management of complications and critical care within the last two
decades. Studies reported by many authors from 1970 to 2012 may
further add to the information bias.
When major abdominal surgery is considered in the elderly, a
thorough pre-operative assessment leads to a risk-benefit profile
for the individual patient. Several previously identified
co-morbidities must be weighed against the potential benefits of
the surgery. In general, every pancreaticoduodenectomy candidate
must be considered carefully on an individual basis. Even in
patients where a complete R0 resection of a peri-ampulary cancer
can be achieved, the patient’s pre-operative physiological condi-
tion may preclude curative surgery. As a result, it is the authors’
conclusion that it would be very difficult to conduct an adequate
prospective randomized controlled trial evaluating this topic.
Conclusion
There is an increased incidence of post-operative mortality and
pneumonia after a PD among all elderly patients75 years of age,
as well as an increased incidence of post-operative complications
among patients 80 years of age. However, the increased preva-
lence of pre-operative comorbidities among elderly patients may
have introduced significant selection bias when compared with
younger, healthier cohorts. Additional randomized control trials
studying post-PD operative outcomes in elderly vs. younger
patients with standardization of comorbidities is therefore neces-
sary to confirm the conclusions presented here.
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